KALV - Financial Reports List - KalVista Pharmaceuticals, Inc. - IntrinsicAlpha

KalVista Pharmaceuticals, Inc. KALV

Healthcare - Biotechnology - NASDAQ - US

$ 11.42

-3.02 %

$ 568 M

Market Cap

-3.15

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q3	8-K	2025-01-31	0.00%	-67.11%	-29.53%
Quarterly Report	Q2	8-K	2024-10-31	0.00%	-52.87%	-54.01%
Quarterly Report	Q1	8-K	2024-07-31	0.00%	-59.75%	-51.98%
Quarterly Report	Q4	8-K	2024-04-30	0.00%	-11.53%	-52.72%
Annual Report	FY	10-K	2024-04-30	0.00%	-69.19%	-26.67%
Quarterly Report	Q3	8-K	2024-01-31	0.00%	-102.54%	-23.03%
Quarterly Report	Q2	8-K	2023-10-31	0.00%	-49.47%	-14.92%
Quarterly Report	Q1	8-K	2023-07-31	0.00%	-9.87%	-10.55%
Quarterly Report	Q4	8-K	2023-04-30	0.00%	-80.70%	-18.34%
Annual Report	FY	10-K	2023-04-30	0.00%	-9.26%	-14.76%

1